GSK (GSK) plans to seek an FDA label update for its leucovorin product as the Trump administration touts the drug's potential ...
The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.
The DARWIN EU links national databases to deliver real-world evidence that supports safer and faster regulatory decisions.
Pharmaceutical Technology on MSN
Roche bids to broaden MS pipeline and strengthen Ocrevus influence
Data at ECTRIMS will help back fenebrutinib as a potential addition to Roche’s arsenal of drugs, and help cement Ocrevus’s ...
ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
Medical journals and National Comprehensive Cancer Network guidelines rarely publish FDA-identified uncertainties about new ...
2don MSN
Trump links autism to acetaminophen use during pregnancy, despite decades of evidence it’s safe
President Donald Trump announced Monday that the US Food and Drug Administration will be notifying physicians that the use of ...
Scientists say that Trump distorted facts on vaccines, Tylenol and autism during a news conference in which he encouraged pregnant women not to take the drug.
President Donald Trump claimed Monday that acetaminophen, the main ingredient in Tylenol, is linked to autism, despite ...
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback